In a research report released today, Cantor Fitzgerald analyst Irina Rivkind maintained a Buy rating on Eagle Pharma (NASDAQ:EGRX) with a $30 price …
In a report released today, Cantor Fitzgerald analyst Irina Rivkind maintained a Buy rating on Hyperion Therapeutics, Inc. (NASDAQ:HPTX) but lowered the price target …
In a report issued today, Cantor Fitzergald analyst Irina Rivkind reiterated a Buy rating on Valeant Pharmaceuticals International (NYSE:VRX) with a $167 price target, …
In a research report released today, Cantor Fitzgerald analyst Irina Rivkind maintained a Hold rating on Ligand Pharmaceuticals (LGND) and raised her price target to $49 (from $45), as her big picture …
In a research report released today, Cantor Fitzgerald analyst Irina Rivkind maintained a Hold rating on Assembly Biosciences (NASDAQ:ASMB), and raised her price target to $6.50 (from $6.
In a research report released today, Cantor Fitzgerald analyst Irina Rivkind maintained a Buy rating on Synergy Pharmaceuticals (SGYP), with a $11 price target. The report follows the company’s …
In a research note released yesterday, Cantor Fitzgerald analyst Irina Rivkind reiterated a Hold rating on Jazz Pharmaceuticals (JAZZ) with a $151 price …
In a research note released yesterday, Cantor Fitzgerald analyst Irina Rivkind reiterated a Buy rating on Sucampo Pharmaceuticals (SCMP) with a $12 price target, following the company’s second …
